Grifols

Phone: +3434-93 571 00 00

Fax: 34-93 571 02 67

Web:https://www.grifols.com

TypeSociedad Anónima
Traded as
ISINES0171996012
IndustryPharmaceuticals, chemicals
Founded1940
HeadquartersBarcelona, Spain
Key peopleVíctor Grífols Deu and Raimon Grifols Roura (Chairmen and CEOs)
ProductsPlasma derivatives, in vitro diagnostic products, non-biological products for laboratories and hospitals
Revenue
  • Increase €3.934 billion (2015)
  • €3.355 billion (2014)
Operating income
  • Increase €970.4 million (2015)
  • €857.7 million (2014)
Net income
  • Increase €532.1 million (2015)
  • €470.3 million (2014)
Total assets
  • Increase €9.601 billion (2015)
  • €8,449.7 million (2014)
Total equity
  • Increase €3.3014 billion (2015)
  • €2,662.9 million (2014)
Number of employees
  • Increase 21,500 (2019, average)
Websitewww.grifols.com

Grifols is a global healthcare company that since 1909 has enhanced the health and well-being of people around the world. We are an industry leader in producing plasma-derived medicines and transfusion medicine. Our business is organized into four divisions: Bioscience, Diagnostic, Hospital and Bio Supplies. We sell our products and services in more than 100 countries and regions and have subsidiaries in 30 of them. We aim to be a global leader in our markets and an industry reference for quality, safety and innovation.

For detailed contact information visit location pages below.

Grifols's locations around the world

EuropeExpand

Clinical Trials sponsored by Grifols

Подписаться